Key Aspects of Analytical Development MasterClass - EU edition
26-27 February, 2024
Key elements for a successful development of a drug product analytical development
The analytical aspects of the control strategy will be covered as well analytical documents for the submission.
26-27 February, 2024, Virtual
Time Zone: UTC/GMT+1/CET
The field of analytical development as part of the development of a new or generic drug product covers a huge range from the translation of the Quality Target Product Profile (QTPP) into the Analytical Target Profile (ATP) over the entire analytical procedure life cycle (i.e., development, validation, transfer, and maintenance of new analytical procedures) to key contribution to the control strategy of the commercial product (including definition of Critical Quality Attributes (CQAs), establishing of specification and justification for specification). In addition to these key elements for a successful development of a drug product analytical development is a key player in the stability studies and for the definition of the shelf-life of the medicinal product. Several regulatory documents are around analytical development which provide guidance to the key elements to this CMC topic such as the ICH guidelines for Pharmaceutical Development (Q8 (R2)), Analytical Development (Q14), Method Validation (Q2 (R2)), Specification (Q6A & Q6B), Impurities of new drug substances and products (Q3A & Q3B), and Stability testing (Q1A to Q1E). In addition, further scientific information can be found in pharmacopeial general chapters of the USP. These guidance documents form the basis of this course around analytical development. In detail, the focus of this course is on the specification of drug substances and products and it´s justification, determination of Critical Quality Attributes (CQAs), life cycle of analytical procedures, analytical documentation in terms of procedure content and validation / transfer of methods, and stability studies for drug substances and products.
Furthermore, the analytical aspects of the control strategy will be covered as well analytical documents for the submission.
#masterclass #glceurope #pharmaonlinetraining #globalleadingconferences #keyaspects #analyticaldevelopment
Manfred Fischer Consulting
Who should attend?
• Analytical Development
• Formulation Development
• Project Management
• Pre-clinical Development
• Clinical Development
• CMC Regulatory Affairs
• Quality Control
• Quality Assurance
• Drug Substance Manufacture
• Drug Product Manufacture
"High attention to detail in course content and very well delivered"
Product Development Manager
"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"
USP PD Team Manager
"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today it’s an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.know more >
Years of experience
Other events you may like
07-08 December, 2023
Current regulatory requirements to perform a structured assessment of cross-contamination risks.learn more >>
11-12 December, 2023
The course will cover serialisation and aggregation of medicinal productslearn more >>
12-15 December, 2023
This comprehensive and detailed online masterclass describes the PK/PD studies from an industrial perspective to achieve a successful regulatory submission.learn more >>